Safety and Efficacy of Co-Administration of Sitagliptin and Metformin in China (MK-0431-121)

Clinical trial NCT01076088 · COMPLETED

Trial details

NCT number: NCT01076088
Sponsor: Merck Sharp & Dohme LLC
Status: COMPLETED
Phase: Phase 3
Study type: INTERVENTIONAL

Type 2 Diabetes Mellitus

Start date: 2010-11-15
Primary completion: 2012-12-24
Enrollment: 744

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.